Drugs / insulin lispro LM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00393705 Comparator | Oct 2006 → Mar 2009 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | insulin lispro LM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00393705 ↗ |
| Route | Subcutaneous | “injected subcutaneously” NCT00393705 ↗ |